Meningococcal polysaccharide diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria.

The latest research study released by Market IntelliX evaluates market size and forecasts of Meningococcal Polysaccharide Vaccine in global, including the following market information:

Global Meningococcal Polysaccharide Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Meningococcal Polysaccharide Vaccine Market Sales, 2017-2022, 2023-2028, (K Doses)

Global top five Meningococcal Polysaccharide Vaccine companies in 2021 (%)

The global Meningococcal Polysaccharide Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Polysaccharide Meningtitis AC Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Meningococcal Polysaccharide Vaccine include Sanofi, Bio-Med, CanSinoBIO, Walvax Biotechnology, Chongqing Zhifei Biological, Chengdu Kanghua Biological Products, Changsheng Biotechnology and CanSinoBIO, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MI has surveyed the Meningococcal Polysaccharide Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Market Segmentations:

Global Meningococcal Polysaccharide Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Meningococcal Polysaccharide Vaccine Market Segment Percentages, by Type, 2021 (%)

Polysaccharide Meningtitis AC

Meningitis ACYW

Global Meningococcal Polysaccharide Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Meningococcal Polysaccharide Vaccine Market Segment Percentages, by Application, 2021 (%)

6 Months-15Year

over 3 Year

over 2 Year

over 3 Months

Global Meningococcal Polysaccharide Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Meningococcal Polysaccharide Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Meningococcal Polysaccharide Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Meningococcal Polysaccharide Vaccine revenues share in global market, 2021 (%)

Key companies Meningococcal Polysaccharide Vaccine sales in global market, 2017-2022 (Estimated), (K Doses)

Key companies Meningococcal Polysaccharide Vaccine sales share in global market, 2021 (%)

The report presents profiles of competitors in the market, Some of the prominent key players covered:

Sanofi

Bio-Med

CanSinoBIO

Walvax Biotechnology

Chongqing Zhifei Biological

Chengdu Kanghua Biological Products

Changsheng Biotechnology

CanSinoBIO

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1 Introduction to Research & Analysis Reports

1.1 Meningococcal Polysaccharide Vaccine Market Definition

1.2 Market Segments

1.2.1 Market by Type

1.2.2 Market by Application

1.3 Global Meningococcal Polysaccharide Vaccine Market Overview

1.4 Features & Benefits of This Report

1.5 Methodology & Sources of Information

1.5.1 Research Methodology

1.5.2 Research Process

1.5.3 Base Year

1.5.4 Report Assumptions & Caveats

2 Global Meningococcal Polysaccharide Vaccine Overall Market Size

2.1 Global Meningococcal Polysaccharide Vaccine Market Size: 2021 VS 2028

2.2 Global Meningococcal Polysaccharide Vaccine Revenue, Prospects & Forecasts: 2017-2028

2.3 Global Meningococcal Polysaccharide Vaccine Sales: 2017-2028

3 Company Landscape

3.1 Top Meningococcal Polysaccharide Vaccine Players in Global Market

3.2 Top Global Meningococcal Polysaccharide Vaccine Companies Ranked by Revenue

3.3 Global Meningococcal Polysaccharide Vaccine Revenue by Companies

3.4 Global Meningococcal Polysaccharide Vaccine Sales by Companies

3.5 Global Meningococcal Polysaccharide Vaccine Price by Manufacturer (2017-2022)

3.6 Top 3 and Top 5 Meningococcal Polysaccharide Vaccine Companies in Global Market, by Revenue in 2021

3.7 Global Manufacturers Meningococcal Polysaccharide Vaccine Product Type

3.8 Tier 1, Tier 2 and Tier 3 Meningococcal Polysaccharide Vaccine Players in Global Market

3.8.1 List of Global Tier 1 Meningococcal Polysaccharide Vaccine Companies

3.8.2 List of Global Tier 2 and Tier 3 Meningococcal Polysaccharide Vaccine Companies

4 Sights by Product

4.1 Overview

4.1.1 By Type - Global Meningococcal Polysaccharide Vaccine Market Size Markets, 2021 & 2028

4.1.2 Polysaccharide Meningtitis AC

4.1.3 Meningitis ACYW

4.2 By Type - Global Meningococcal Polysaccharide Vaccine Revenue & Forecasts

4.2.1 By Type - Global Meningococcal Polysaccharide Vaccine Revenue, 2017-2022

4.2.2 By Type - Global Meningococcal Polysaccharide Vaccine Revenue, 2023-2028

4.2.3 By Type - Global Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028

4.3 By Type - Global Meningococcal Polysaccharide Vaccine Sales & Forecasts

4.3.1 By Type - Global Meningococcal Polysaccharide Vaccine Sales, 2017-2022

4.3.2 By Type - Global Meningococcal Polysaccharide Vaccine Sales, 2023-2028

4.3.3 By Type - Global Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028

4.4 By Type - Global Meningococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2017-2028

5 Sights By Application

5.1 Overview

5.1.1 By Application - Global Meningococcal Polysaccharide Vaccine Market Size, 2021 & 2028

5.1.2 6 Months-15Year

5.1.3 over 3 Year

5.1.4 over 2 Year

5.1.5 over 3 Months

5.2 By Application - Global Meningococcal Polysaccharide Vaccine Revenue & Forecasts

5.2.1 By Application - Global Meningococcal Polysaccharide Vaccine Revenue, 2017-2022

5.2.2 By Application - Global Meningococcal Polysaccharide Vaccine Revenue, 2023-2028

5.2.3 By Application - Global Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028

5.3 By Application - Global Meningococcal Polysaccharide Vaccine Sales & Forecasts

5.3.1 By Application - Global Meningococcal Polysaccharide Vaccine Sales, 2017-2022

5.3.2 By Application - Global Meningococcal Polysaccharide Vaccine Sales, 2023-2028

5.3.3 By Application - Global Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028

5.4 By Application - Global Meningococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2017-2028

6 Sights by Region

6.1 By Region - Global Meningococcal Polysaccharide Vaccine Market Size, 2021 & 2028

6.2 By Region - Global Meningococcal Polysaccharide Vaccine Revenue & Forecasts

6.2.1 By Region - Global Meningococcal Polysaccharide Vaccine Revenue, 2017-2022

6.2.2 By Region - Global Meningococcal Polysaccharide Vaccine Revenue, 2023-2028

6.2.3 By Region - Global Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028

6.3 By Region - Global Meningococcal Polysaccharide Vaccine Sales & Forecasts

6.3.1 By Region - Global Meningococcal Polysaccharide Vaccine Sales, 2017-2022

6.3.2 By Region - Global Meningococcal Polysaccharide Vaccine Sales, 2023-2028

6.3.3 By Region - Global Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028

6.4 North America

6.4.1 By Country - North America Meningococcal Polysaccharide Vaccine Revenue, 2017-2028

6.4.2 By Country - North America Meningococcal Polysaccharide Vaccine Sales, 2017-2028

6.4.3 US Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.4.4 Canada Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.4.5 Mexico Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.5 Europe

6.5.1 By Country - Europe Meningococcal Polysaccharide Vaccine Revenue, 2017-2028

6.5.2 By Country - Europe Meningococcal Polysaccharide Vaccine Sales, 2017-2028

6.5.3 Germany Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.5.4 France Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.5.5 U.K. Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.5.6 Italy Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.5.7 Russia Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.5.8 Nordic Countries Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.5.9 Benelux Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.6 Asia

6.6.1 By Region - Asia Meningococcal Polysaccharide Vaccine Revenue, 2017-2028

6.6.2 By Region - Asia Meningococcal Polysaccharide Vaccine Sales, 2017-2028

6.6.3 China Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.6.4 Japan Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.6.5 South Korea Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.6.6 Southeast Asia Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.6.7 India Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.7 South America

6.7.1 By Country - South America Meningococcal Polysaccharide Vaccine Revenue, 2017-2028

6.7.2 By Country - South America Meningococcal Polysaccharide Vaccine Sales, 2017-2028

6.7.3 Brazil Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.7.4 Argentina Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.8 Middle East & Africa

6.8.1 By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue, 2017-2028

6.8.2 By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Sales, 2017-2028

6.8.3 Turkey Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.8.4 Israel Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.8.5 Saudi Arabia Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

6.8.6 UAE Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

7 Manufacturers & Brands Profiles

7.1 Sanofi

7.1.1 Sanofi Corporate Summary

7.1.2 Sanofi Business Overview

7.1.3 Sanofi Meningococcal Polysaccharide Vaccine Major Product Offerings

7.1.4 Sanofi Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)

7.1.5 Sanofi Key News

7.2 Bio-Med

7.2.1 Bio-Med Corporate Summary

7.2.2 Bio-Med Business Overview

7.2.3 Bio-Med Meningococcal Polysaccharide Vaccine Major Product Offerings

7.2.4 Bio-Med Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)

7.2.5 Bio-Med Key News

7.3 CanSinoBIO

7.3.1 CanSinoBIO Corporate Summary

7.3.2 CanSinoBIO Business Overview

7.3.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Major Product Offerings

7.3.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)

7.3.5 CanSinoBIO Key News

7.4 Walvax Biotechnology

7.4.1 Walvax Biotechnology Corporate Summary

7.4.2 Walvax Biotechnology Business Overview

7.4.3 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Major Product Offerings

7.4.4 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)

7.4.5 Walvax Biotechnology Key News

7.5 Chongqing Zhifei Biological

7.5.1 Chongqing Zhifei Biological Corporate Summary

7.5.2 Chongqing Zhifei Biological Business Overview

7.5.3 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Major Product Offerings

7.5.4 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)

7.5.5 Chongqing Zhifei Biological Key News

7.6 Chengdu Kanghua Biological Products

7.6.1 Chengdu Kanghua Biological Products Corporate Summary

7.6.2 Chengdu Kanghua Biological Products Business Overview

7.6.3 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Major Product Offerings

7.6.4 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)

7.6.5 Chengdu Kanghua Biological Products Key News

7.7 Changsheng Biotechnology

7.7.1 Changsheng Biotechnology Corporate Summary

7.7.2 Changsheng Biotechnology Business Overview

7.7.3 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Major Product Offerings

7.7.4 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)

7.7.5 Changsheng Biotechnology Key News

7.8 CanSinoBIO

7.8.1 CanSinoBIO Corporate Summary

7.8.2 CanSinoBIO Business Overview

7.8.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Major Product Offerings

7.8.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)

7.8.5 CanSinoBIO Key News

8 Global Meningococcal Polysaccharide Vaccine Production Capacity, Analysis

8.1 Global Meningococcal Polysaccharide Vaccine Production Capacity, 2017-2028

8.2 Meningococcal Polysaccharide Vaccine Production Capacity of Key Manufacturers in Global Market

8.3 Global Meningococcal Polysaccharide Vaccine Production by Region

9 Key Market Trends, Opportunity, Drivers and Restraints

9.1 Market Opportunities & Trends

9.2 Market Drivers

9.3 Market Restraints

10 Meningococcal Polysaccharide Vaccine Supply Chain Analysis

10.1 Meningococcal Polysaccharide Vaccine Industry Value Chain

10.2 Meningococcal Polysaccharide Vaccine Upstream Market

10.3 Meningococcal Polysaccharide Vaccine Downstream and Clients

10.4 Marketing Channels Analysis

10.4.1 Marketing Channels

10.4.2 Meningococcal Polysaccharide Vaccine Distributors and Sales Agents in Global

11 Conclusion

12 Appendix

12.1 Note

12.2 Examples of Clients

12.3 Disclaimer

List of Tables

Table 1. Key Players of Meningococcal Polysaccharide Vaccine in Global Market

Table 2. Top Meningococcal Polysaccharide Vaccine Players in Global Market, Ranking by Revenue (2021)

Table 3. Global Meningococcal Polysaccharide Vaccine Revenue by Companies, (US$, Mn), 2017-2022

Table 4. Global Meningococcal Polysaccharide Vaccine Revenue Share by Companies, 2017-2022

Table 5. Global Meningococcal Polysaccharide Vaccine Sales by Companies, (K Doses), 2017-2022

Table 6. Global Meningococcal Polysaccharide Vaccine Sales Share by Companies, 2017-2022

Table 7. Key Manufacturers Meningococcal Polysaccharide Vaccine Price (2017-2022) & (US$/Dose)

Table 8. Global Manufacturers Meningococcal Polysaccharide Vaccine Product Type

Table 9. List of Global Tier 1 Meningococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 10. List of Global Tier 2 and Tier 3 Meningococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 11. By Type – Global Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 & 2028

Table 12. By Type - Global Meningococcal Polysaccharide Vaccine Revenue (US$, Mn), 2017-2022

Table 13. By Type - Global Meningococcal Polysaccharide Vaccine Revenue (US$, Mn), 2023-2028

Table 14. By Type - Global Meningococcal Polysaccharide Vaccine Sales (K Doses), 2017-2022

Table 15. By Type - Global Meningococcal Polysaccharide Vaccine Sales (K Doses), 2023-2028

Table 16. By Application – Global Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 & 2028

Table 17. By Application - Global Meningococcal Polysaccharide Vaccine Revenue (US$, Mn), 2017-2022

Table 18. By Application - Global Meningococcal Polysaccharide Vaccine Revenue (US$, Mn), 2023-2028

Table 19. By Application - Global Meningococcal Polysaccharide Vaccine Sales (K Doses), 2017-2022

Table 20. By Application - Global Meningococcal Polysaccharide Vaccine Sales (K Doses), 2023-2028

Table 21. By Region – Global Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 VS 2028

Table 22. By Region - Global Meningococcal Polysaccharide Vaccine Revenue (US$, Mn), 2017-2022

Table 23. By Region - Global Meningococcal Polysaccharide Vaccine Revenue (US$, Mn), 2023-2028

Table 24. By Region - Global Meningococcal Polysaccharide Vaccine Sales (K Doses), 2017-2022

Table 25. By Region - Global Meningococcal Polysaccharide Vaccine Sales (K Doses), 2023-2028

Table 26. By Country - North America Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2022

Table 27. By Country - North America Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2023-2028

Table 28. By Country - North America Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2017-2022

Table 29. By Country - North America Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2023-2028

Table 30. By Country - Europe Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2022

Table 31. By Country - Europe Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2023-2028

Table 32. By Country - Europe Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2017-2022

Table 33. By Country - Europe Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2023-2028

Table 34. By Region - Asia Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2022

Table 35. By Region - Asia Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2023-2028

Table 36. By Region - Asia Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2017-2022

Table 37. By Region - Asia Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2023-2028

Table 38. By Country - South America Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2022

Table 39. By Country - South America Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2023-2028

Table 40. By Country - South America Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2017-2022

Table 41. By Country - South America Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2023-2028

Table 42. By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2022

Table 43. By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2023-2028

Table 44. By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2017-2022

Table 45. By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2023-2028

Table 46. Sanofi Corporate Summary

Table 47. Sanofi Meningococcal Polysaccharide Vaccine Product Offerings

Table 48. Sanofi Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)

Table 49. Bio-Med Corporate Summary

Table 50. Bio-Med Meningococcal Polysaccharide Vaccine Product Offerings

Table 51. Bio-Med Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)

Table 52. CanSinoBIO Corporate Summary

Table 53. CanSinoBIO Meningococcal Polysaccharide Vaccine Product Offerings

Table 54. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)

Table 55. Walvax Biotechnology Corporate Summary

Table 56. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product Offerings

Table 57. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)

Table 58. Chongqing Zhifei Biological Corporate Summary

Table 59. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product Offerings

Table 60. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)

Table 61. Chengdu Kanghua Biological Products Corporate Summary

Table 62. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product Offerings

Table 63. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)

Table 64. Changsheng Biotechnology Corporate Summary

Table 65. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product Offerings

Table 66. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)

Table 67. CanSinoBIO Corporate Summary

Table 68. CanSinoBIO Meningococcal Polysaccharide Vaccine Product Offerings

Table 69. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)

Table 70. Meningococcal Polysaccharide Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)

Table 71. Global Meningococcal Polysaccharide Vaccine Capacity Market Share of Key Manufacturers, 2020-2022

Table 72. Global Meningococcal Polysaccharide Vaccine Production by Region, 2017-2022 (K Doses)

Table 73. Global Meningococcal Polysaccharide Vaccine Production by Region, 2023-2028 (K Doses)

Table 74. Meningococcal Polysaccharide Vaccine Market Opportunities & Trends in Global Market

Table 75. Meningococcal Polysaccharide Vaccine Market Drivers in Global Market

Table 76. Meningococcal Polysaccharide Vaccine Market Restraints in Global Market

Table 77. Meningococcal Polysaccharide Vaccine Raw Materials

Table 78. Meningococcal Polysaccharide Vaccine Raw Materials Suppliers in Global Market

Table 79. Typical Meningococcal Polysaccharide Vaccine Downstream

Table 80. Meningococcal Polysaccharide Vaccine Downstream Clients in Global Market

Table 81. Meningococcal Polysaccharide Vaccine Distributors and Sales Agents in Global Market

List of Figures

Figure 1. Meningococcal Polysaccharide Vaccine Segment by Type

Figure 2. Meningococcal Polysaccharide Vaccine Segment by Application

Figure 3. Global Meningococcal Polysaccharide Vaccine Market Overview: 2021

Figure 4. Key Caveats

Figure 5. Global Meningococcal Polysaccharide Vaccine Market Size: 2021 VS 2028 (US$, Mn)

Figure 6. Global Meningococcal Polysaccharide Vaccine Revenue, 2017-2028 (US$, Mn)

Figure 7. Meningococcal Polysaccharide Vaccine Sales in Global Market: 2017-2028 (K Doses)

Figure 8. The Top 3 and 5 Players Market Share by Meningococcal Polysaccharide Vaccine Revenue in 2021

Figure 9. By Type - Global Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028

Figure 10. By Type - Global Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028

Figure 11. By Type - Global Meningococcal Polysaccharide Vaccine Price (US$/Dose), 2017-2028

Figure 12. By Application - Global Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028

Figure 13. By Application - Global Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028

Figure 14. By Application - Global Meningococcal Polysaccharide Vaccine Price (US$/Dose), 2017-2028

Figure 15. By Region - Global Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028

Figure 16. By Region - Global Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028

Figure 17. By Country - North America Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028

Figure 18. By Country - North America Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028

Figure 19. US Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 20. Canada Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 21. Mexico Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 22. By Country - Europe Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028

Figure 23. By Country - Europe Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028

Figure 24. Germany Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 25. France Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 26. U.K. Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 27. Italy Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 28. Russia Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 29. Nordic Countries Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 30. Benelux Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 31. By Region - Asia Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028

Figure 32. By Region - Asia Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028

Figure 33. China Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 34. Japan Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 35. South Korea Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 36. Southeast Asia Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 37. India Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 38. By Country - South America Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028

Figure 39. By Country - South America Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028

Figure 40. Brazil Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 41. Argentina Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 42. By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028

Figure 43. By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028

Figure 44. Turkey Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 45. Israel Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 46. Saudi Arabia Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 47. UAE Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028

Figure 48. Global Meningococcal Polysaccharide Vaccine Production Capacity (K Doses), 2017-2028

Figure 49. The Percentage of Production Meningococcal Polysaccharide Vaccine by Region, 2021 VS 2028

Figure 50. Meningococcal Polysaccharide Vaccine Industry Value Chain

Figure 51. Marketing Channels

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)